+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Checkpoint-Inhibitor Refractory Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Checkpoint-Inhibitor Refractory Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Chemotherapy-Induced Hearing Loss - Pipeline Insight, 2025 - Product Thumbnail Image

Chemotherapy-Induced Hearing Loss - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Pediatric Brain Tumors - Pipeline Insight, 2025 - Product Thumbnail Image

Pediatric Brain Tumors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
ER Positive, HER2 Negative Breast Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

ER Positive, HER2 Negative Breast Cancer- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
CAR T-Cell Therapy For Multiple Myeloma - Pipeline Insight, 2025 - Product Thumbnail Image

CAR T-Cell Therapy For Multiple Myeloma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 40 Pages
  • Global
From
Myc Proto Oncogene Protein - Pipeline Insight, 2025 - Product Thumbnail Image

Myc Proto Oncogene Protein - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Pheochromocytoma- Pipeline Insight, 2025 - Product Thumbnail Image

Pheochromocytoma- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
KRAS Mutant Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

KRAS Mutant Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Untreated Metastatic Or Unresectable Melanoma- Pipeline Insight, 2025 - Product Thumbnail Image

Untreated Metastatic Or Unresectable Melanoma- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
HER2-mutant Non-Small Cell Lung Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

HER2-mutant Non-Small Cell Lung Cancer- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Advanced Merkel Cell Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Advanced Merkel Cell Carcinoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Advanced Melanoma - Pipeline Insight, 2025 - Product Thumbnail Image

Advanced Melanoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 180 Pages
  • Global
From
Janus Kinase (JAK) Inhibitors- Pipeline Insight, 2025 - Product Thumbnail Image

Janus Kinase (JAK) Inhibitors- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 150 Pages
  • Global
From
Acral Lentiginous Melanoma - Pipeline Insight, 2025 - Product Thumbnail Image

Acral Lentiginous Melanoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Gastric Neuroendocrine Tumors - Pipeline Insight, 2025 - Product Thumbnail Image

Gastric Neuroendocrine Tumors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Gorlin-syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Gorlin-syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Wilms Tumor - Pipeline Insight, 2025 - Product Thumbnail Image

Wilms Tumor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
AIDS Related Kaposi's Sarcoma - Pipeline Insight, 2025 - Product Thumbnail Image

AIDS Related Kaposi's Sarcoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more